Skip to main content

Table 2 Motility test pre- and post-chronic MPTPp treatment

From: Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease

TOTAL ACTIVITY
  Pre-treatment Post-treatment
  Mean SEM Mean SEM
  Vehicle 11503.75 983.49 8737.50 1651.77
  MPTPp 5803.80 1162.18 6587 771.63
  MPTPp + SZV558 9063.14 1055.95 7904.85 982.36
  MPTPp + Rasagiline 9941.57 1055.57 8867.85 1214.24
LOCOMOTOR ACTIVITY
  Vehicle 8727 983.49 3690.25 1651.77
  MPTPp 4004.60 916.64 2773.40 343.84
  MPTPp + SZV558 6929.85 791.63 3415.86 463.68
  MPTPp + Rasagiline 7497 928.82 3938 639.83
  1. Motor activity was measured 2 days before the first MPTPp administration and 1 day after the last MPTPp administration. Values are expressed as mean ± SEM
  2. Data were statistically compared with one-way ANOVA, followed by the Newman–Keuls post hoc test
  3. Number of independent experiments: 4–7/group